Mental Health and Dysphonia: Which Comes First, and Does That Change Care Utilization?


Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
05 2020
Historique:
received: 16 04 2019
revised: 22 06 2019
accepted: 09 07 2019
pubmed: 9 2 2020
medline: 1 9 2020
entrez: 9 2 2020
Statut: ppublish

Résumé

Voice patients with voice disorders have a high prevalence of distress and mental health (MH) comorbidities, but it is unknown to what extent distress precedes or follows voice disorder diagnoses. Objectives were to compare 1) proportions of voice patients with MH diagnoses who received MH diagnoses first versus voice-related diagnoses first, 2) voice-related diagnoses and care utilization, and 3) time to specialty evaluation in each group. Patients with voice and MH diagnoses were identified using International Classification of Diseases, Ninth and Tenth Revisions codes in a large health system data repository from January 2005 through July 2017. Sociodemographics, comorbidities, MH- and voice-related diagnoses, and voice-related care utilization were analyzed using descriptive statistics and multivariable regression modeling. Among the 11,419 patients with both voice and MH diagnoses, 63% (n = 7,251) received MH diagnoses prior to voice diagnoses, compared with 37% with a voice diagnosis first (P < 0.0001). The latter group received more specific voice-related diagnoses (e.g., laryngeal cancer [odds ratio (OR) 4.27], benign laryngeal neoplasm [OR 1.60]), and were more likely to ever see an otolaryngologist than those receiving MH diagnoses first (P < 0.0001). Most patients with voice and MH diagnoses received a MH diagnosis first. Patients who receive MH diagnoses first appeared to have different voice-related healthcare compared to those who received voice diagnoses first. NA Laryngoscope, 130:1243-1248, 2020.

Identifiants

pubmed: 32034963
doi: 10.1002/lary.28203
pmc: PMC7269068
mid: NIHMS1592106
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1243-1248

Subventions

Organisme : NIDCD NIH HHS
ID : K23 DC016335
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000114
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002494
Pays : United States

Informations de copyright

© 2019 The American Laryngological, Rhinological and Otological Society, Inc.

Références

Ear Nose Throat J. 2003 Oct;82(10):808-10, 812, 814
pubmed: 14606179
Lancet. 2012 Jul 7;380(9836):37-43
pubmed: 22579043
Otolaryngol Head Neck Surg. 2001 Sep;125(3):176-82
pubmed: 11555751
Laryngoscope. 2012 Jul;122(7):1582-8
pubmed: 22544473
J Commun Disord. 2013 Mar-Apr;46(2):125-42
pubmed: 23273707
Clin Otolaryngol. 2016 Feb;41(1):2-7
pubmed: 25973976
J Voice. 2019 May;33(3):382.e11-382.e20
pubmed: 29198815
J Voice. 2000 Dec;14(4):521-48
pubmed: 11130110
Ann Otol Rhinol Laryngol. 2006 Feb;115(2):128-34
pubmed: 16514796
Laryngoscope. 2020 Jun;130(6):1496-1502
pubmed: 31508825
Folia Phoniatr Logop. 2011;63(6):281-8
pubmed: 21430386
Laryngoscope. 2016 Aug;126(8):1859-64
pubmed: 26691195
Clin Epidemiol. 2017 Jun 02;9:311-320
pubmed: 28652813
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Psychiatry Res. 2005 Mar 30;134(1):85-91
pubmed: 15808293
Swiss Med Wkly. 2005 Jul 9;135(27-28):387-97
pubmed: 16220409
Am J Med. 2015 Apr;128(4):426.e11-8
pubmed: 25460527
J Voice. 2008 Jul;22(4):472-88
pubmed: 18395419
J Voice. 2019 Jan 16;:
pubmed: 30660338
JAMA. 2016 Sep 13;316(10):1104-5
pubmed: 27623464
Laryngoscope. 2011 Sep;121(9):2004-10
pubmed: 22024857
Laryngoscope. 2015 Jul;125(7):1660-6
pubmed: 25676541
Br J Cancer. 2016 Aug 23;115(5):533-41
pubmed: 27490803

Auteurs

Victoria A Jordan (VA)

Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, Minnesota.

Seth Cohen (S)

Duke Voice Care Center, Division of Otolaryngology-Head & Neck Surgery, Duke University Medical Center, Durham, North Carolina, U.S.A.

Scott Lunos (S)

Clinical and Translational Science Institute, Biostatistical Design and Analysis Center, University of Minnesota, Minneapolis, Minnesota.

Keith J Horvath (KJ)

School of Public Health, Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota.

Gretchen Sieger (G)

Clinical and Translational Science Institute, Best Practices Integrated Informatics Core, University of Minnesota, Minneapolis, Minnesota.

Stephanie Misono (S)

Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, Minnesota.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH